Optimizing Cutpoints for Clinical Interpretation of Brain Amyloid Status Using Plasma P-Tau217 Immunoassays.

Daniel J. Figdore,Michael Griswold,Joshua A. Bornhorst,Jonathan Graff-Radford,Vijay K. Ramanan,Prashanthi Vemuri,Val J. Lowe,David S. Knopman,Clifford R. Jack,Ronald C. Petersen,Alicia Algeciras-Schimnich

ALZHEIMERS & DEMENTIA（2024）

引用 4|浏览4

关键词

Alzheimer's disease,amyloid pathology,amyloid positron emission tomography,blood-based biomarkers,cutpoints,Fujirebio Lumipulse,immunoassays,plasma phosphorylated tau217,Simoa ALZpath

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要